OMRT-14. Small molecule circadian clock compounds exhibit potential as a novel therapy paradigm for glioblastoma

Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor type, claiming the lives of patients within 2 years of diagnosis. The major challenges in treating GBM are largely due to the biological characteristics of the tumor and the brain and pharmacokinetics of many drug...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Adv
Main Authors: Chan, Priscilla, Hirota, Tsuyoshi, Qu, Meng, Zhang, Guoxin, Shah, Khalid, Wakimoto, Hiroaki, Kamenecka, Theodore, Solt, Laura, Rich, Jeremy, Kay, Steve
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Supplement Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255417/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab070.038
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares